Martin Pešta
- Cancer Research top 2%
- MicroRNA in disease regulation 18
- Cancer-related molecular mechanisms research 15
- Cancer Genomics and Diagnostics 10
- Protease and Inhibitor Mechanisms 8
- Oncology top 10%
- Peptidase Inhibition and Analysis 10
- Colorectal Cancer Treatments and Studies 8
- Molecular Biology top 10%
- Circular RNAs in diseases 12
-
- Lung Cancer Treatments and Mutations 8
- Genetics top 10%
Martin Pešta
91 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 119
- Cancer Research 801
- Oncology 414
- Molecular Biology 834
- Pulmonary and Respiratory Medicine 290
- Genetics 80
Countries citing papers authored by Martin Pešta
This map shows the geographic impact of Martin Pešta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Pešta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Pešta more than expected).
Fields of papers citing papers by Martin Pešta
This network shows the impact of papers produced by Martin Pešta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Pešta. The network helps show where Martin Pešta may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Martin Pešta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 10 | |
| 2 | 2023 | 5 | |
| 3 | 2022 | 16 | |
| 4 | 2021 | 9 | |
| 5 | 2020 | 4 | |
| 6 | 2019 | 33 | |
| 7 | 2019 | 3 | |
| 8 | 2017 | 15 | |
| 9 | 2017 | 6 | |
| 10 | 2016 | 23 | |
| 11 | 2015 | 43 | |
| 12 | 2014 | 24 | |
| 13 | 2014 | 28 | |
| 14 | 2012 | 19 | |
| 15 | Characterization of P19 cells during retinoic acid induced differentiation. | 2010 | 7 |
| 16 | 2010 | 15 | |
| 17 | 2010 | 130 | |
| 18 | 2009 | 2 | |
| 19 | Nádorové markery karcinomu prostaty | 2008 | 1 |
| 20 | 2007 | 1 |
About Martin Pešta
Martin Pešta is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 97 papers that have together received 1.7k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (18 papers), Cancer-related molecular mechanisms research (15 papers), Circular RNAs in diseases (12 papers), Cancer Genomics and Diagnostics (10 papers), Peptidase Inhibition and Analysis (10 papers), Protease and Inhibitor Mechanisms (8 papers), Colorectal Cancer Treatments and Studies (8 papers) and Lung Cancer Treatments and Mutations (8 papers). The work is most often cited by research in Cancer Research (801 citations), Oncology (414 citations) and Molecular Biology (834 citations). Martin Pešta has collaborated with scholars based in Czechia, Germany and United States. Frequent co-authors include Ondřej Topolčan, Vlastimil Kulda, L Holubec, Vladislav Třeška, Jiří Polívka, Marie Ludvíková, Václav Liška, Olga Golubnitschaja, Pavel Dvořák and Jindřich Fínek. Their work appears in journals such as Journal of Clinical Oncology, Neuroscience and European Heart Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.